Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Payables (2020 - 2026)

NeuroPace has reported Payables over the past 7 years, most recently at $4.5 million for Q1 2026.

  • For Q1 2026, Payables rose 11.52% year-over-year to $4.5 million; the TTM value through Mar 2026 reached $4.5 million, up 11.52%, while the annual FY2025 figure was $2.2 million, 24.95% down from the prior year.
  • Payables for Q1 2026 was $4.5 million at NeuroPace, up from $2.2 million in the prior quarter.
  • Over five years, Payables peaked at $4.7 million in Q2 2025 and troughed at $1.2 million in Q3 2022.
  • A 5-year average of $2.6 million and a median of $2.2 million in 2022 define the central range for Payables.
  • On a YoY basis, Payables climbed as much as 112.5% in 2025 and fell as far as 24.95% in 2025.
  • Year by year, Payables stood at $2.1 million in 2022, then grew by 8.62% to $2.3 million in 2023, then rose by 26.67% to $3.0 million in 2024, then decreased by 24.95% to $2.2 million in 2025, then surged by 103.52% to $4.5 million in 2026.
  • Business Quant data shows Payables for NPCE at $4.5 million in Q1 2026, $2.2 million in Q4 2025, and $4.6 million in Q3 2025.